About: Biomaterials Access Assurance Act of 1998

Facets (new session)
Description
Metadata
Settings
- Rule:
- Inverse Functional Properties:
- "Same As":

About: Biomaterials Access Assurance Act of 1998 Goto Sponge NotDistinct Permalink

An Entity of Type : owl:Thing, within Data Space : dbpedia.demo.openlinksw.com associated with source document(s)
QRcode icon

http://dbpedia.demo.openlinksw.com/describe/?url=http%3A%2F%2Fdbpedia.org%2Fresource%2FBiomaterials_Access_Assurance_Act_of_1998

Biomaterials Access Assurance Act of 1998 is a United States federal statute establishing liability exemptions for biomaterial suppliers selling chemical components and raw materials utilized in implantable devices for human recipients. The United States federal legislation sets forth rules limiting litigation costs or unwarranted lawsuits for biomaterial suppliers excluded from the design, production, and testing of implantable devices demonstrated as effective and safe to include adequate product warnings.

Attributes	Values
rdfs:label	Biomaterials Access Assurance Act of 1998 (en)
rdfs:comment	Biomaterials Access Assurance Act of 1998 is a United States federal statute establishing liability exemptions for biomaterial suppliers selling chemical components and raw materials utilized in implantable devices for human recipients. The United States federal legislation sets forth rules limiting litigation costs or unwarranted lawsuits for biomaterial suppliers excluded from the design, production, and testing of implantable devices demonstrated as effective and safe to include adequate product warnings. (en)
foaf:homepage	http://U.S.
dcterms:subject	1998 in the United States Health care quality Regulation of medical devices United States federal health legislation Food and Drug Administration Acts of the 105th United States Congress
Wikipage page ID	51516530 (xsd:integer)
Wikipage revision ID	979122966 (xsd:integer)
Link from a Wikipage to another Wikipage	Presidency of Bill Clinton Bill (law) Biocompatibility Biomaterial Biomaterial Surface Modifications Pennsylvania Republican Party (United States) United States Department of Health and Human Services United States Statutes at Large Contiguous United States Medical Device Regulation Act Sales Chemical substance 1998 in the United States George Gekas Federal preemption Mechanical properties of biomaterials Health care quality Regulation of medical devices Lawsuit Title 21 of the United States Code United States federal health legislation Legislation United States House Committee on the Judiciary Food and Drug Administration Acts of the 105th United States Congress Biopolymer The Delaware Journal of Corporate Law Raw material Implant (medicine) Impleader Surface modification of biomaterials with proteins United States House Committee on Energy and Commerce Medical device manufacturing
Link from a Wikipage to an external page	http://www.djcl.org/wp-content/uploads/2014/08/The-BIOMATERIALS-ACCESS-ASSURANCE-ACT-OF-1998-AND-SUPPLIER-LIABILITY-WHO-YOU-GONNA-SUE.pdf https://www.gpo.gov/fdsys/pkg/STATUTE-112/pdf/STATUTE-112-Pg1519.pdf https://www.biomaterials.org https://www.fda.gov/RegulatoryInformation/Guidances/ucm071003.htm
sameAs	Biomaterials Access Assurance Act of 1998 Biomaterials Access Assurance Act of 1998
title amended	21 (xsd:integer)
dbp:wikiPageUsesTemplate	dbt:Cite_web dbt:Reflist dbt:USBill dbt:Usstat dbt:Infobox_U.S._legislation dbt:Usc-title-chap
cite public law	105 (xsd:integer)
effective date	1998-08-13 (xsd:date)
introducedby	George Gekas (en)
introduceddate	1997-02-27 (xsd:date)
introducedin	House (en)
passedbody	House (en) Senate (en)
passeddate	1998-07-30 (xsd:date)
passedvote	Passed unanimous consent (en) Passed without objection (en)
public law url	https://www.gpo.gov/fdsys/pkg/STATUTE-112/pdf/STATUTE-112-Pg1519.pdf
shorttitle	Biomaterials Access Assurance Act of 1998 (en)
signeddate	1998-08-13 (xsd:date)
signedpresident	William J. Clinton (en)
committees	United States House Committee on the Judiciary United States House Committee on Energy and Commerce
enacted by	105 (xsd:integer)
nickname	Biomaterials Access Assurance Act of 1997 (en)
has abstract	Biomaterials Access Assurance Act of 1998 is a United States federal statute establishing liability exemptions for biomaterial suppliers selling chemical components and raw materials utilized in implantable devices for human recipients. The United States federal legislation sets forth rules limiting litigation costs or unwarranted lawsuits for biomaterial suppliers excluded from the design, production, and testing of implantable devices demonstrated as effective and safe to include adequate product warnings. The H.R. 872 bill was passed by the 105th United States Congressional session and enacted into law by the 42nd President of the United States Bill Clinton on August 13, 1998. (en)
longtitle	An Act to establish rules governing product liability actions against raw materials and bulk component suppliers to medical device manufacturers, and for other purposes. (en)
sections created	§ 1601 et seq. (en)
prov:wasDerivedFrom	wikipedia-en:Biomaterials_Access_Assurance_Act_of_1998?oldid=979122966&ns=0
page length (characters) of wiki page	6956 (xsd:nonNegativeInteger)
foaf:isPrimaryTopicOf	wikipedia-en:Biomaterials_Access_Assurance_Act_of_1998
is Link from a Wikipage to another Wikipage of	List of acts of the 105th United States Congress Timeline of the Bill Clinton presidency (1998) 105th United States Congress Title 21 of the United States Code
is foaf:primaryTopic of	wikipedia-en:Biomaterials_Access_Assurance_Act_of_1998

Faceted Search & Find service v1.17_git139 as of Feb 29 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 08.03.3330 as of Mar 19 2024, on Linux (x86_64-generic-linux-glibc212), Single-Server Edition (378 GB total memory, 60 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software